The Discounted Cash Flow (DCF) valuation of Vertex Pharmaceuticals Inc (VRTX) is (15.94) USD. With the latest stock price at 501.15 USD, the upside of Vertex Pharmaceuticals Inc based on DCF is -103.2%.
Based on the latest price of 501.15 USD and our DCF valuation, Vertex Pharmaceuticals Inc (VRTX) is a sell. selling Vertex stocks now will result in a potential gain of 103.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.3% - 9.7% | 8.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (49.30) - (4.25) | (15.94) |
| Upside | -109.8% - -100.8% | -103.2% |